|Articles|June 24, 2016
Automation in Aseptic Processing
Advertisement
Chris Procyshyn, CEO of Vanrx, sat down with BioPharm International to discuss automation in aseptic processing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
5